![Oncocyte Corporation](/common/images/company/N_OCX.png)
Oncocyte Corporation (OCX)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -82.184 | -157.118 | -159.664 | -90.836 | -62.831 | -59.63 | -56.554 | -32.829 |
Return on Equity (%) | -110.143 | -271.644 | -402.607 | -130.913 | -93.071 | -129.882 | -147.569 | -104.905 |
Return on Invested Capital (%) | -106.249 | -236.445 | -323.037 | -193.131 | -151.968 | -148.6 | 8.68 | -55.806 |
Operating Margin (%) | N/A | N/A | N/A | N/A | -2543.914 | -946.668 | -1934.76 | -1650.233 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | -2461.513 | -829.52 | -7664.092 | -1911.045 |
Book Value Per Share | 0.309 | 0.116 | 0.084 | 0.541 | 0.134 | -0.485 | -0.186 | -3.753 |
Earnings Per Share | -0.389 | -0.616 | -0.387 | -0.393 | -0.433 | -0.695 | -0.619 | -3.477 |
Cash Per Share | 0.354 | 0.242 | 0.198 | 0.387 | 0.103 | 0.386 | 0.169 | 1.142 |
Working Capital Per Share | 0.293 | 0.13 | 0.076 | 0.325 | 0.003 | 0.271 | 0.113 | 0.424 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | 0.054 | 0.049 | 0.261 | 0.747 |
EBIT Per Share | -0.389 | -0.616 | -0.387 | -0.393 | -0.451 | -0.795 | -0.157 | -3.009 |
EBITDA Per Share | -0.389 | -0.616 | -0.387 | -0.393 | -0.451 | -0.795 | -0.157 | -3.009 |
Free Cash Flow Per Share | -0.398 | -0.632 | -0.4 | -0.383 | -0.421 | -0.717 | -0.626 | -3.646 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 28.74M | 31.45M | 40.66M | 57.03M | 69.12M | 92.23M | N/A | N/A |
Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 118.61M | 118.62M | N/A | 119.28M | N/A | 8.26M | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | 2009.764 | N/A | N/A | N/A | -5178.409 |
Net Profit Margin (%) | N/A | N/A | N/A | 1021.212 | N/A | N/A | N/A | -5186.932 |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 41.71M |
Price to Earnings Ratio | -1.46 |
Price to Sales Ratio | 5.78 |
Price to Cash Ratio | 4.45 |
Price to Book Ratio | 1.64 |
Dividend Yield | - |
Shares Outstanding | 13.37M |
Average Volume (1 week) | 3.57k |
Average Volume (1 Month) | 15.77k |
52 Week Change | -5.71% |
52 Week High | 4.34 |
52 Week Low | 2.08 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.